PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PerCP/Cy5.5 anti-mouse TCR γ/δ, 25 μg
PerCP/Cy5.5 anti-mouse TER-119/Erythroid Cells, 100 μg
PerCP/Cy5.5 anti-mouse TER-119/Erythroid Cells, 25 μg
PerCP/Cy5.5 anti-mouse/human CD11b, 100 μg
PerCP/Cy5.5 anti-mouse/human CD11b, 25 μg
PerCP/Cy5.5 anti-mouse/human CD44, 100 μg
PerCP/Cy5.5 anti-mouse/human CD44, 25 μg
PerCP/Cy5.5 anti-mouse/human CD45R/B220, 100 μg
PerCP/Cy5.5 anti-mouse/human CD45R/B220, 25 μg
PerCP/Cy5.5 anti-mouse/human GL7 Antigen (T and B cell Activation Marker), 100 μg
PerCP/Cy5.5 anti-mouse/human GL7 Antigen (T and B cell Activation Marker), 25 μg
PerCP/Cy5.5 anti-mouse/human Helios, 100 tests
PerCP/Cy5.5 anti-mouse/human Helios, 25 tests
PerCP/Cy5.5 anti-mouse/human KLRG1 (MAFA), 100 μg
PerCP/Cy5.5 anti-mouse/human KLRG1 (MAFA), 25 μg
PerCP/Cy5.5 anti-mouse/rat CD29, 100 μg